All Companies
Ticker NRSN
Below our internal liquidity threshold
You reached the page — here's exactly what NRSN is, and why it's out of scope for now.
What this ticker is
NRSN
Neurosense Therapeutics Ltd.
NASDAQ
Healthcare
Biotechnology
Why we can't analyze it yet
Below internal liquidity floor — trades ~$91,003/day (~$1,911,063/mo), under our $500,000/day minimum; too thin to trade
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
below_liquidity